🇺🇸 FDA
Pipeline program

BILINDA GYNIAL 0,03 mg/2 mg Filmtabletten, Selina Gynial 0,03 mg/0,15 mg Filmtabletten

Approved small_molecule active

Quick answer

BILINDA GYNIAL 0,03 mg/2 mg Filmtabletten, Selina Gynial 0,03 mg/0,15 mg Filmtabletten for Hormonal contraception is a Approved program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Hormonal contraception
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials